| |
Treatment effects
|
Heterogeneity
| |
|---|
|
Outcome
|
n
|
MD (95% CI)
|
P
|
tau2 (95% CI)
|
I2 (95% CI)
|
95% prediction
|
|---|
|
Anterior joint space
|
2
|
− 0.72 (− 0.90, − 0.54)
|
< 0.001
|
0 (0, 2.25)
|
4% (0%, 99%)
|
NC
|
|
Posterior joint space
|
2
|
1.03 (0.87, 1.19)
|
< 0.001
|
0 (0, 1.41)
|
0% (0%, 98%)
|
NC
|
|
Superior joint space
|
2
|
0.72 (0.48, 0.96)
|
< 0.001
|
0 (0, 3.92)
|
0% (0%, 99%)
|
NC
|
|
Anterior angle
|
2
|
0.57 (− 3.90, 5.03)
|
0.80
|
4.71 (NC)
|
45% (NC)
|
NC
|
|
Posterior angle
|
3
|
− 7.28 (− 16.67, 1.11)
|
0.09
|
47.61 (7.23, 921.80)
|
90% (7%, 99%)
|
− 110.45, 95.90
|
|
Condylar coronary width
|
2
|
1.12 (0.06 2.19)
|
0.04
|
0.50 (0, 75.91)
|
83% (0%, 100%)
|
NC
|
|
Glenoid fossa sagittal displacement
|
2
|
− 0.30 (− 0.74, 0.14)
|
0.18
|
0.01 (0, 12.63)
|
11% (0%, 99%)
|
NC
|
|
Glenoid fossa vertical displacement
|
2
|
− 0.39 (− 0.70, − 0.08)
|
0.01
|
0 (0, 5.027)
|
0% (0%, 99%)
|
NC
|
|
Sagittal concentricity
|
2
|
1.29 (− 22.33, 24.91)
|
0.92
|
288.29 (NC)
|
99% (NC)
|
NC
|
- CI confidence interval, MD mean difference, NC noncalculable
